ABSTRACT
INTRODUCTION
Arthritis is a longstanding, debilitating disease that results in serious sequle on the population. It causes pain, impairment, and disability in patients with increasing injury to the cartilage, synovium and bone of the affected joints (1) .
Existing methods to diagnose and to monitor the disease are based on late clinical manifestations of arthritis. However, with recent development of successful treatments for rheumatoid arthritis and osteoarthritis, it becomes important to identify prognostic factors that can predict the evolution of arthritis. This would be of most value in the early phases of the disease so that treatments could be started rapidly to help slow down progression of the disease
(1).
A possible approach to monitor arthritis is the measurement of biological markers of cartilage repair and degradation to reflect variations in joint remodeling. One such potential biological marker of arthritis is cartilage oligomeric matrix protein (COMP) (2).
COMP is also known as thrombospondin 5. It is a 524 kDa homopentameric extracellular matrix glycoprotein member of the thrombospondin family of calciumbinding proteins with five identical subunits (3&4) . The function of COMP remains unclear, but it may have a structural role in endochondral ossification and in the assembly and stabilization of the extracellular matrix by its interaction with collagen fibrils and matrix components (5&6) . COMP was first detected in the serum and the synovial fluid of patients suffering from rheumatoid disorders, such as RA, reactive arthritis, juvenile chronic arthritis, and osteoarthritis (OA) 
SUBJECTS & METHODS
The study included 50 subjects; they were classified into 2 main groups: There are significantly higher values of HA, COMP, CRP and ESR in RA patients when compared to controls. There are no significant differences in the number of patients, gender, duration of RA disease, DAS and RF status. However, there is a significant difference as regarding the age of the patients, also the patients who had rapid erosion have a significant higher Larsen score than those with slow erosion. There are significantly higher values of COMP and HA in RA patients with disease duration more than 2 years, in more erosive Larsen patients group and in high more than moderate and mild DAS. However, There are no significant differences in the serum levels of COMP and HA in RF seropositive and RF seronegative patient groups. There are significant positive correlations between serum levels of COMP and HA with age, disease duration, Larsen score, DAS, CRP and ESR. There is significant positive correlation between serum levels of COMP and HA. 
RESULTS

DISCUSSION
Rheumatoid arthritis (RA) is a disease characterized by destruction of joint structures such as articular cartilage and bone (2) . The pathogenic mechanisms responsible for tissue destruction are not well understood (26) . Furthermore, it is not clear why joint destruction progresses very slowly in some patients and causes little tissue derangement, whereas in others extensive destruction occurs within a few years after disease onset (27&2) . The use of immunoassays for the quantification of cartilage and bone molecules which enter the circulation as part of tissue turnover that occur in RA, has reflected the changes in the metabolism of extracellular matrix in these tissues (27) .
The present study demonstrated that there are no significant differences in the number of patients, gender, duration of RA, DAS and RF status in the rapid erosive and the slow erosive patient groups. However, there is a significant difference as regard the age of the patients, also the patients who had rapid erosion have a significant higher Larsen score than those with slow erosion.
Majeed et al. and Young et al.
( 28&29) , have reported that there were no significant differences in gender, age of patients, disease duration, RF positivity and DAS. However, the patients with radiographic progression had a higher Larsen score. The present study demonstrated a significant increase in serum levels of HA in RA patients compared with control group, using cut off point of 60 ng/ml, test sensitivity was 42.6% and specificity was 71.1%. The levels of HA were higher in the rapid erosive group than in the slow erosive group, these results agreed with those of
Santos et al. and Majeed et al. (30&28)
who suggested that an increased systemic level might act as an early indicator of structural damage and hence provide a useful prognostic marker.
Elliott et al. (15) have reported that HA is produced locally by cells of the ECM, degradation and turnover of the ECM result in release of HA and HA fragments into the systemic circulation. Increased production and release of HA from arthritis joints are thought to reflect the localized inflammation of synovial lining and, to a lesser extent, to cartilage degradation.
Chubinskaya et al.
(30) have postulated that levels of HA were higher in RA patients than in asymptomatic donors. These results, also, go with those of Pothacharoen et al.
(32) who suggested that RA may be detected systemically according to these results.
In the current study, RA patients showed a significant increase of COMP compared with the control group, using a cut off value of 15.17 μg/ml, test sensitivity was 72.6% and specificity was 79%.
The levels of COMP were higher in the rapid erosive group than in the slow erosive group, these results agreed with those of Poole et al. (2) have reported that COMP and other cartilage and bone biomarkers will serve as more useful prognostic markers than current predictors such as anti-cyclic citrullinated peptide (ACCP), radiographic damage early in the disease course, and signs of inflammation.
The present study demonstrated a significant increase in serum levels of CRP and ESR in RA patients compared with control group. The levels of CRP and ESR were higher in the rapid erosive group than in the slow erosive group, these results agreed with those of Bengt et al. and Majeed et al. (27&28) In the current study, significant positive correlations between serum levels of HA and age of the patients at disease onset, disease duration, DAS and Larsen score were detected, in accordance to results reported by Emlen et al. (36) In the current study, a significant positive correlation was detected between serum levels of HA and ESR and CRP as recorded by Bengt et al.
(27) , a finding which supports a connection between joint and systemic inflammation.
Majeed et al.
(28) demonstrated that HA serum levels are correlated with measures of disease activity including swollen joint count, tender joint count and pain VAS. However, there is a strong positive correlation with laboratory indices of disease activity (ESR and CRP) rather than with the clinical indices of the disease.
In the current study, significant positive correlations between serum levels of COMP and age of the patients at disease onset, disease duration, DAS and Larsen score were detected. These results agreed with those of Wislowska and Jablonska, (37) who reported that serum COMP levels were correlated to the age of RA patients and DAS value.
Marti et al. (41,42&43) who reported that serum COMP levels correlated with ESR and CRP, which are indicators of the acute-phase response, these findings suggest that serum COMP levels may reflect cartilage destruction..
In the current study, There are significantly higher values of COMP and HA in RA patients with disease duration more than 2 years, in more erosive Larsen group patients and in high more than moderate and mild DAS. However, there are no significant differences in the serum levels of COMP and HA in RF seropositive and RF seronegative patient groups.
Momohara et al.
have postulated that COMP serum levels of the patients with least erosive disease (LES) group were significantly lower than those of the patients with more erosive disease (MES) group. YoungMin et al. (29) have reported that increased COMP serum levels in RA patients are correlated significantly with radiographic progression of the disease, which indicate that COMP is a useful predictor of radiographic progression in RA.
Majeed et al. (28) found that no significant difference was found in HA serum levels between RF seropositive and RF seronegative patients.
A significant positive correlation between serum levels of HA and COMP was found in the present study, a similar result was reported by Bengt et al. (27) Serum COMP was found to be a specific marker for the cartilage degradation in RA and not related to the nonspecific inflammatory process, as there was a significant difference in levels when compared to patients with other inflammatory rheumatic diseases with less cartilage-destructive arthritis Consequently, it could be concluded that the measurement of some serological biomarkers that reflect bone and cartilage destruction in RA patients (COMP and HA) could be used to investigate disease activity and increase the knowledge of the basic pathophysiology of joint disease. These observations draw attention to the fact that the measurement of cartilage derived macromolecules could be used for prognostic purposes and in therapeutic studies. 
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